Evren Receives Certificate of Registration for the Mark Phoenix®

Updated: Dec 23, 2020

Gainesville, FL – November 10, 2020

Evren was notified today that its Mark PHOENIX had been issued a U.S. Trademark Registration covering medical devices for delivering neuro-stimulation and neuromodulation for treating psychological and neuropsychological disorders, including PTSD and other indications.

“We are delighted that our Phoenix® Mark has finally made it through the registration process in the United States. There are pending applications for the Phoenix in several international locations as well,” said Blythe Karow, President & CEO of Evren Technologies, “We chose the name Phoenix® for our PTSD treatment as it gives the connotation of a thing of beauty being reborn from a tragic situation, which is how we hope our customers will feel when using the Phoenix® to treat their PTSD.”

About Evren Technologies

Evren Technologies is a development stage bioelectronic medicine company at the forefront of two of the most rapidly-growing spaces in the medical device industry: Vagal Nerve Stimulation (VNS), and wearable tech. We are bringing cutting-edge VNS technology to a user-friendly and intelligent hardware and software platform that is easy to use and personalized. Our initial product - the Phoenix® - delivers transcutaneous auricular vagal nerve stimulation in a discreet earbud design for the treatment of Post-Traumatic Stress Disorder (PTSD).


M. Blythe Karow

President and CEO

Evren Technologies, Inc.

352.533.3381 x702


12 views0 comments


Evren Technologies, Inc.

404 SW 140th Terrace

Suite 50

Newberry, FL 32669


Tel: 352-533-3381


  • Black Facebook Icon
  • Black Twitter Icon
  • LinkedIn - Black Circle

© Copyright 2020 Evren Technologies, Inc. All rights reserved.